Kolexia
Hocine Faycal Oncologie médicale
Hocine Faycal
Oncologie médicale
Centre De Traitements Hautes Energies
Amiens, France
45 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du côlon Tumeurs colorectales Tumeurs de l'oesophage Fragilité {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Ammarguellat Hanifa
Ammarguellat Hanifa
Centre Hospitalier de Beauvais, Beauvais, France
Gozy Michel
Gozy Michel
Sa Sainte-isabelle, Abbeville, France
Ramdane Soraya
Ramdane Soraya
Centre Hospitalier de Beauvais, Beauvais, France
Phlips Patricia
Phlips Patricia
Sa Sainte-isabelle, Abbeville, France

Industries

Voir plus
Ipsen
9 collaboration(s)
Dernière en 2023
AstraZeneca
8 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023
Janssen
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LOGICAN: Randomised Phase II Study Evaluating Trifluridine/Tipiracil Plus Oxaliplatin ± Nivolumab Versus FOLFOX ± Nivolumab in Patients With Gastric, Oesophagus or Gastroesophageal Junction Adenocarcinoma Locally Advanced, Recurrent or Metastatic, Ineligible for Triplet Chemotherapy
Essai Clinique (Servier)   12 octobre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
TEDOPAM: A Randomized Non-comparative Phase II Study of Maintenance Therapy With OSE2101 Plus FOLFIRI, or FOLFIRI After Induction Therapy With FOLFIRINOX in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPaM-D17-01 PRODIGE 63 Study)
Essai Clinique (Ose Immunotherapeutics)   24 février 2023
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 septembre 2022
394P Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34-FFCD 1402-ADAGE randomized phase III trial
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
1566TiP PRODIGE 65 - UCGI 36 - GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}